HighTower Advisors’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

HighTower Advisors’s Portfolio TLOG Stock Details TLOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-27,870	Closed	-$5K	–	2102
2016 Q3	$5K	Hold	27,870	–	–	﹤0.01%	1864
2016 Q2	$8K	Hold	27,870	–	–	﹤0.01%	1724
2016 Q1	$5K	Sell	27,870 -5,000	-15%	-$1.39K	﹤0.01%	2053
2015 Q4	$57K	Sell	32,870 -28,644	-47%	-$50.5K	﹤0.01%	1887
2015 Q3	$114K	Hold	61,514	–	–	﹤0.01%	1724
2015 Q2	$144K	Hold	61,514	–	–	﹤0.01%	1400
2015 Q1	$269K	Hold	61,514	–	–	﹤0.01%	1293
2014 Q4	$296K	Sell	61,514 -5,000	-8%	-$22.4K	﹤0.01%	1233
2014 Q3	$277K	Hold	66,514	–	–	﹤0.01%	1236
2014 Q2	$392K	Hold	66,514	–	–	0.01%	1141
2014 Q1	$424K	Buy	+66,514	New	+$600K	0.01%	1041

Other funds holding TLOG

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BWA

Burt Wealth Advisors North Bethesda, Maryland $407M AUM 11.98% 1-Year Est. Return

HighTower Advisors's TLOG Position: Q4 2016 in Review

HighTower Advisors sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q4 2016, closing a stake of 27,870 shares — an estimated $5K sold.

HighTower Advisors first reported a position in TLOG in Q1 2014 and held it in 11 quarters. The position peaked at $424K in Q1 2014. 3 funds tracked by Wall St. Rank hold TLOG as of Q4 2016.

HighTower Advisors reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q4 2016 after selling out during the quarter.
HighTower Advisors sold 27,870 TetraLogic Pharmaceuticals Corporation shares in Q4 2016, an estimated $5K.
HighTower Advisors first reported a position in TetraLogic Pharmaceuticals Corporation in Q1 2014 and held it in 11 quarters.
HighTower Advisors's TetraLogic Pharmaceuticals Corporation position peaked at $424K in Q1 2014.
3 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q4 2016.

Based on HighTower Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.